中国普通外科杂志2016，Vol.25Issue(9)：1351-1356,6.DOI:10.3978/j.issn.1005-6947.2016.09.022
胰腺癌的分子靶向治疗研究进展
Research progress in molecular targeted therapy for pancreatic cancer
钟志惟(综述) 1殷香保(审校)1
作者信息
- 1. 南昌大学第二附属医院 肝胆胰外科，江西 南昌 330006
- 折叠
摘要
Abstract
Pancreatic cancer is one of most malignant tumors with extremely poor prognosis, and the 5-year survival rate of the patients is below 5%. Conventional treatments produce very limited effects for pancreatic cancer, and it requires multidisciplinary approach and comprehensive management. With the deepening knowledge of molecular biology, molecular targeted drugs such as epidermal growth factor receptor inhibitors have shown impressive potential in treatment of pancreatic cancer. Here, the authors present the current status and progress in molecular targeted drug research for pancreatic cancer.关键词
胰腺肿瘤/分子靶向治疗/综述文献Key words
Pancreatic Neoplasms/Molecular Targeted hTerapy/Review分类
医药卫生引用本文复制引用
钟志惟(综述),殷香保(审校)..胰腺癌的分子靶向治疗研究进展[J].中国普通外科杂志,2016,25(9):1351-1356,6.
